Multiple sclerosis (MS) is a chronic disease of the central nervous system in which the immune system attacks myelin, the protective sheath surrounding nerve fibres in the brain and spinal cord. This demyelination disrupts the transmission of nerve signals and can produce a wide range of symptoms, including numbness…
Multiple sclerosis (MS) is a chronic disease of the central nervous system in which the immune system attacks myelin, the protective sheath surrounding nerve fibres in the brain and spinal cord. This demyelination disrupts the transmission of nerve signals and can produce a wide range of symptoms, including numbness and tingling, muscle weakness or paralysis, fatigue, problems with vision and coordination, and cognitive changes. MS most often begins in young adults and is more common in women than in men. The cause of MS is not fully understood but is thought to involve autoimmune, genetic, and environmental factors, and its course varies, frequently following a relapsing-remitting pattern. Research addresses the biology of myelin and oligodendrocytes, disease severity and prognosis, rehabilitation, and the use of rigorous clinical-trial methods to evaluate therapies. The journal publishes peer-reviewed studies relevant to these themes, including a randomized pilot trial of ultraviolet B phototherapy in MS, coping strategies among people with MS during the pandemic, implementation of evidence-based occupational therapy for rehabilitation, disability and prognostic factors of MS severity in a cohort study, neurovascular reactivity after relapses, oligodendrocyte development and Wnt signalling, and methodological work on the early use of blinding in neurological clinical research.
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 12 articles above have been cited 38 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Multiple Sclerosis, linking to each citing work.